The Role of Mitochondria in Cellular Stress and Disease

Mitochondrial Dynamics: Fission, Fusion, and Mitophagy

The mitochondria are dynamic organelles in the sense that they continuously undergo fission (division) and fusion, merging to maintain their function and integrity. Collectively, these processes are referred to as mitochondrial dynamics and are involved in ensuring that mitochondria work correctly.

Mitochondrial fusion enables the mixing of mitochondrial contents to reduce mitochondrial damage by complementing defective mitochondria with functional ones. On the contrary, mitochondrial fusion has to occur for chaperone-mediated removal of damaged mitochondria by mitophagy, a specialized form of autophagy. This ensures that only healthy mitochondria are retained within the cell and thus prevents the buildup of dysfunctional mitochondria that accentuates cellular stress and subsequently leads to disease.

The disruption of mitochondrial dynamics may result in the accumulation of the damaged mitochondria, making them less efficient at producing ATP but more likely to generate ROS. Thus, the levels of oxidative stress would increase, with enhanced possibilities for cell death. More precisely, the balance between mitochondrial fusion and fission is changed in pathologies such as cancer, which subsequently changes cellular metabolism rates and cellular survival rates.

Mitochondria in Apoptosis and Cell Death

Mitochondria are one of the main regulators of apoptosis, a programmed cell death that prevents anomalies in tissue structure and maintains homeostasis by eliminating damaged or dangerous cells. During the process of apoptosis, mitochondria release some pro-apoptotic factors into the cytosol, which include cytochrome c; this initiates the activity of the caspases, enzymes executing programmed cell death.

The choice for apoptosis is tightly regulated by the quality control of mitochondrial dynamics and the fine balance of pro-apoptotic and anti-apoptotic signals in the cell. Under the influence of cellular stress, such as DNA damage, oxidative stress, or nutrient deprivation, this balance is titled towards apoptosis, and cells die. Nevertheless, this process is in fact compromised in some diseases, such as cancer, because it prevents the cells from undergoing apoptosis and, despite the damage, continues to proliferate.

They are also implicated in the process of necrosis, a type of cell death that is basically attributed to the uncontrolled release of cellular contents that subsequently leads to inflammation and tissue damage. In contrast to apoptosis, which is a regulated process, necrosis is usually a consequence of severe mitochondrial dysfunction and the collapse of cellular energy-producing machinery.

Mitochondria and Inflammation

The mitochondria not only have a role in cell death but also participate in the regulation of inflammation. In the process of self-destruction, mitochondria can release damage-associated molecular patterns, such as mitochondrial DNA, into the cytosol or extracellular space. These DAMPs may induce innate immune responses to activate the production of pro-inflammatory cytokines and activate immune cells.

These organelles have been implicated in a variety of inflammatory diseases, including rheumatoid arthritis, systemic lupus erythematosus, an illness that combines characteristics of rheumatism and erythema, and inflammatory bowel disease. In these conditions, continuous activation of the immune system by mitochondrial DAMPs promotes inflammation and tissue damage.

Furthermore, mitochondrially produced ROS are signaling molecules that can modulate the activity of inflammatory pathways, thus further linking dysfunction to inflammation. Interplay between mitochondria and inflammation is thus another critical frontier in research, since it indicates potential therapeutic targets for treating inflammatory diseases.

Mitochondrial Transfer and Therapeutic Implications

The most fascinating discovery of recent studies is the phenomenon of mitochondrial intercellular transmission. In what became known as horizontal mitochondrial transfer, mitochondria move through various mechanisms, such as tunneling nanotubes, from cell to cell. Mitochondrial transfer rescued mitochondrial function in recipient cells and thus holds some potential for therapeutic applications in conditions characterized by mitochondrial dysfunction.

In neurodegenerative disease models, the transfer of healthy mitochondria to damaged neurons restored cellular function and decreased disease pathology. Likewise, in disorders such as myocardial infection, it has been suggested that mitochondrial transfer might be a means of restoring mitochondrial activity in damaged heart tissue.

Research on the possible therapeutic potential of mitochondrial transfer is still underway, but it nonetheless signals a very promising way forward in combining diseases that are a result of mitochondrial malfunction. Understanding this process better with regard to which molecules are transferred between cells will enable new therapies that use the process to improve the health of cells and eventually cure many diseases.

Conclusion

Mitochondria are key to cell health, and their failure can lead to a host of diseases. Although the roles of mitochondria in processes such as energy production and the maintenance of redox balance appear very isolated, they place them squarely at the center of a host of cellular functions, particularly in apoptosis, inflammation, and cellular stress responses. The interwoven complex relationship of mitochondrial function with disease will hold the key to a new therapeutic strategy that will mitigate the consequences of mitochondrial dysfunction and improve cellular health.

With further research into the intricate mechanisms of how the mitochondria act on cellular stress and disease, there is growing potential to target mitochondria in therapeutic interventions. In the near future, mitochondrial medicine may yield great promise for some of the most challenging diseases of our time by modulating mitochondrial dynamics, preventing oxidative stress, and promoting mitochondrial transfer.

References

1. Youle, R.J., 2019. Mitochondria—Striking a balance between host and endosymbiont. Science, 365(6454), p.eaaw9855.
2. Torralba, D., Baixauli, F. and Sánchez-Madrid, F., 2016. Mitochondria know no boundaries: mechanisms and functions of intercellular mitochondrial transfer. Frontiers in cell and developmental biology, 4, p.107.
3. Shneyer, B.I., Ušaj, M. and Henn, A., 2016. Myo19 is an outer mitochondrial membrane motor and effector of starvation-induced filopodia. Journal of cell science, 129(3), pp.543-556.
4. Wilson, C. and González-Billault, C., 2015. Regulation of cytoskeletal dynamics by redox signaling and oxidative stress: implications for neuronal development and trafficking. Frontiers in cellular neuroscience, 9, p.381.
5. Davis, C.H.O., Kim, K.Y., Bushong, E.A., Mills, E.A., Boassa, D., Shih, T., Kinebuchi, M., Phan, S., Zhou, Y., Bihlmeyer, N.A. and Nguyen, J.V., 2014. Transcellular degradation of axonal mitochondria. Proceedings of the National Academy of Sciences, 111(26), pp.9633-9638.
6. Sheng, Z.H., 2014. Mitochondrial trafficking and anchoring in neurons: new insight and implications. Journal of Cell Biology, 204(7), pp.1087-1098.
7. Hoppins, S. and Nunnari, J., 2012. Mitochondrial dynamics and apoptosis—the ER connection. Science, 337(6098), pp.1052-1054.
8. Youle, R.J. and Van Der Bliek, A.M., 2012. Mitochondrial fission, fusion, and stress. Science, 337(6098), pp.1062-1065.